Literature DB >> 19105211

Occult hepatitis C: how convincing are the current data?

Martin-Walter Welker1, Stefan Zeuzem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19105211     DOI： 10.1002/hep.22706

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  25 in total

1.  Investigation of residual hepatitis C virus in presumed recovered subjects.

Authors:  Kei Fujiwara; Robert D Allison; Richard Y Wang; Patricia Bare; Kentaro Matsuura; Cathy Schechterly; Krishna Murthy; Francesco M Marincola; Harvey J Alter
Journal:  Hepatology       Date:  2012-12-06       Impact factor: 17.425

2.  Sequence analysis of hepatitis C virus from patients with relapse after a sustained virological response: relapse or reinfection?

Authors:  Koji Hara; Maria M Rivera; Christopher Koh; Mary Demino; Sandra Page; Pothu Raju Nagabhyru; Barbara Rehermann; T Jake Liang; Jay H Hoofnagle; Theo Heller
Journal:  J Infect Dis       Date:  2013-10-14       Impact factor: 5.226

3.  Hepatitis C virus late relapse after sustained virologic response from interferon and ribavirin treatment as confirmed by RNA sequencing.

Authors:  Yidan Lu; Anton Andonov; David K H Wong
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

Review 4.  Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection.

Authors:  Barbara Rehermann; Robert Thimme
Journal:  Gastroenterology       Date:  2018-09-26       Impact factor: 22.682

5.  Preferential association of hepatitis C virus with CD19+ B cells is mediated by complement system.

Authors:  Richard Y Wang; Patricia Bare; Valeria De Giorgi; Kentaro Matsuura; Kazi Abdus Salam; Teresa Grandinetti; Cathy Schechterly; Harvey J Alter
Journal:  Hepatology       Date:  2016-10-24       Impact factor: 17.425

6.  Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation.

Authors:  Sandra Elmasry; Sanya Wadhwa; Bo-Ram Bang; Linda Cook; Shefali Chopra; Gary Kanel; Brian Kim; Tammy Harper; Zongdi Feng; Keith R Jerome; Jeffrey A Kahn; Takeshi Saito
Journal:  Gastroenterology       Date:  2016-11-09       Impact factor: 22.682

7.  Trace amounts of sporadically reappearing HCV RNA can cause infection.

Authors:  Naga Suresh Veerapu; Su-Hyung Park; Damien C Tully; Todd M Allen; Barbara Rehermann
Journal:  J Clin Invest       Date:  2014-07-08       Impact factor: 14.808

8.  Occult HCV infection: an unexpected finding in a population unselected for hepatic disease.

Authors:  Laura De Marco; Anna Gillio-Tos; Valentina Fiano; Guglielmo Ronco; Vittorio Krogh; Domenico Palli; Salvatore Panico; Rosario Tumino; Paolo Vineis; Franco Merletti; Lorenzo Richiardi; Carlotta Sacerdote
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

Review 9.  The place of immunotherapy in the management of HCV-induced vasculitis: an update.

Authors:  Laurent Chiche; Stanislas Bataille; Gilles Kaplanski; Noemie Jourde
Journal:  Clin Dev Immunol       Date:  2012-08-15

10.  Two distinct functional patterns of hepatitis C Virus (HCV)-specific T cell responses in seronegative, aviremic patients.

Authors:  Yoon Seok Choi; Jung Eun Lee; Seung Joo Nam; Jung Tak Park; Hyon-Suk Kim; Kyu Hun Choi; Beom Seok Kim; Eui-Cheol Shin
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.